Evidence map›Paper›PMID 41263762›Full record

ReviewHistopathology2026

WHO classification of skin tumours: key updates in the fifth edition.

Gabrielle Goldman-Lévy, Raymond Barnhill, Boris C Bastian, Werner Kempf, David Elder, Pedram Gerami, Wayne Grayson, Dmitry Kazakov, Daniela Massi, Jane Messina and 20 more

Abstract readReview
In one paragraph

Review in Histopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Gabrielle Goldman-LévyInternational Agency for Research on Cancer/World Health Organization (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.ORCID https://orcid.org/0000-0002-8289-126X
Raymond BarnhillInstitut Curie (and Faculty of Medicine, Université Paris Cité), Paris, France.ORCID https://orcid.org/0000-0001-8086-8544
Boris C BastianDepartments of Dermatology and Pathology, University of California, San Francisco, California, USA.ORCID https://orcid.org/0000-0003-1836-6062
Werner KempfKempf und Pfaltz Histologische Diagnostik, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-6552-8629
David ElderHospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-4575-2364
Pedram GeramiFeinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.ORCID https://orcid.org/0000-0002-6194-1037
Wayne GraysonUniversity of the Witwatersrand, Johannesburg, South Africa.ORCID https://orcid.org/0000-0001-6303-6092
Dmitry KazakovPathologie Institut Enge, Zürich, Switzerland.ORCID https://orcid.org/0009-0003-2985-2311
Daniela MassiUniversity of Florence, Florence, Italy.ORCID https://orcid.org/0000-0002-5688-5923
Jane MessinaMoffitt Cancer Center and Research Institute, Tampa, Florida, USA.ORCID https://orcid.org/0000-0002-0332-0224
Arnaud de la FouchardièreCentre Léon Bérard, Lyon, France.ORCID https://orcid.org/0000-0003-2251-8241
Alexander J LazarDepartments of Pathology, Dermatology, & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0002-6395-4499
Thomas BrennUniversity of Michigan, Ann Arbor, Michigan, USA.ORCID https://orcid.org/0000-0002-0089-0352
Brian RousCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.ORCID https://orcid.org/0000-0002-7619-461X
Andrew FieldUniversity of NSW Sydney and Notre Dame University, Sydney and St Vincent's Hospital, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0001-9604-4507
Anthony GillRoyal North Shore Hospital, St Leonards, New South Wales, Australia.ORCID https://orcid.org/0000-0002-9447-1967
Jennelle C HodgeDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0002-1770-4042
Joseph D KhouryDepartment of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0003-2621-3584
Katia LeiteUniversity of São Paulo Medical School, São Paulo, Brazil.ORCID https://orcid.org/0000-0002-2615-7730
Shahin SayedDepartment of Pathology, Aga Khan University Hospital, Nairobi, Kenya.ORCID https://orcid.org/0000-0002-3472-511X
Puay Hoon TanLuma Medical Centre, Singapore, Singapore.ORCID https://orcid.org/0000-0002-1052-8605
Rosalie ElenitsasHospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0002-7269-5123
Eduardo CalonjeSt John's Institute of Dermatology, St Thomas' Hospital, London, UK.ORCID https://orcid.org/0000-0001-7475-6423
Lyn M DuncanMassachusetts General Hospital, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-3732-8256
Liang ZhiyongDepartment of Pathology, Molecular Pathology Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0003-4787-2925
Holger MochUniversity of Zürich and University Hospital Zürich, Zürich, Switzerland.ORCID https://orcid.org/0000-0002-7986-2839
Rajendra SinghSummit Health, Woodland Park, Colorado, USA.ORCID https://orcid.org/0000-0003-4420-5561
Harshima WijesingheInternational Agency for Research on Cancer/World Health Organization (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.ORCID https://orcid.org/0000-0002-2847-1440
Ian CreeInternational Agency for Research on Cancer/World Health Organization (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.ORCID https://orcid.org/0000-0001-5007-9456
Dilani LokuhettyInternational Agency for Research on Cancer/World Health Organization (IARC/WHO), Evidence Synthesis and Classification Branch, Lyon, France.ORCID https://orcid.org/0000-0002-4275-3436

Funding

World Health Organization 001
6 · The paper itself

Abstract

The 5th edition of the World Health Organization Classification of Tumours (WCT) serves as a foundation for global diagnostic standards in tumour pathology. Similar to other volumes in this series, the Skin Tumours (Skin5) edition follows a standardized approach. This edition introduces two new chapters: 'Tumours of the nail unit' and 'Metastases to skin', along with new entities across relevant chapters. This review article provides an overview of the updates in Skin5 based on currently published evidence, with emphasis on newly introduced chapters and newly described entities that involve the skin, in particular, epidermal, melanocytic and appendageal tumours.

Indexed as

Skin NeoplasmsHumansMelanomaWorld Health Organizationappendageal tumorshematopoetic and lymphoid tumorskeratinocytic tumorsmelanocytic tumorsnail unit tumorsskin metastasessoft tissue tumors

Identifiers

PMID41263762
PMCPMC12793825

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.